The Neurodevelopmental and Molecular Landscape of Medulloblastoma Subgroups: Current Targets and the Potential for Combined Therapies
PAOLO ALIMONTI
Cancers
View PDFchevron_right
Medulloblastoma: From Molecular Pathology to Therapy
Krzysztof Reiss
Clinical Cancer Research, 2008
View PDFchevron_right
Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification
Nancy Tarbell
Nature Clinical Practice Oncology, 2007
View PDFchevron_right
Pathogenesis of medulloblastoma and current treatment outlook
Wiesława Grajkowska
Medicinal Research Reviews, 2007
View PDFchevron_right
Current therapy and new perspectives in the treatment of medulloblastoma
Meic H Schmidt, MD, MBA
Pediatric Neurology, 1998
View PDFchevron_right
Pediatric medulloblastoma in the molecular era: what are the surgical implications?
Michelle Kameda-Smith
Cancer and Metastasis Reviews, 2020
View PDFchevron_right
New Approaches in Targeted Therapy for Medulloblastoma in Children
Tina Dalianis
Anticancer Research
View PDFchevron_right
A Holistic Review on the Current and Future Status of Biology-Driven and Broad-Spectrum Therapeutic Options for Medulloblastoma
Ariana Pritha
Cureus, 2022
View PDFchevron_right
A contemporary review of molecular candidates for the development and treatment of childhood medulloblastoma
Yigit UYANIKGIL
Child's Nervous System, 2013
View PDFchevron_right
New perspectives in the treatment of adult medulloblastoma in the era of molecular oncology
Girolamo Crisi
Critical Reviews in Oncology/Hematology, 2015
View PDFchevron_right
Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches
Otilia Menyhart
Cancer and Metastasis Reviews, 2020
View PDFchevron_right
Case-based review: pediatric medulloblastoma
DAVID SOLOMON
Neuro-Oncology Practice
View PDFchevron_right
The rationale for targeted therapies in medulloblastoma
Tobey Macdonald
2014
View PDFchevron_right
Unraveling the secrets of Medulloblastoma: a comprehensive review of molecular pathways associated with pathogenesis, therapeutic resistance and potential treatment strategies
tayyaba mumtaz
Journal of Health and Rehabilitation Research, 2024
View PDFchevron_right
Bridging the treatment gap in infant medulloblastoma: molecularly informed outcomes of a globally feasible regimen
gabriela lamas
Neuro-Oncology, 2020
View PDFchevron_right
Pediatric Medulloblastoma: An Updated Review
Kiran Haridas
West Indian Medical Journal, 2016
View PDFchevron_right
The tumor biology and molecular characteristics of medulloblastoma identifying prognostic factors associated with survival outcomes and prognosis
Daniel Nagasawa, Winward Choy, Isaac Yang
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2011
View PDFchevron_right
Review Article-Medulloblastomas: New Directions In Risk Stratification
Prabal Deb
Neurology India, 2006
View PDFchevron_right
Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?
Stefania Bartolini
Cancers, 2022
View PDFchevron_right
Cellular and molecular pathology of medulloblastoma
John Provias, Laurence Becker
Journal of Neuro-Oncology, 1996
View PDFchevron_right
Rethinking medulloblastoma from a targeted therapeutics perspective
Santosh Kesari
Journal of neuro-oncology, 2018
View PDFchevron_right
Medulloblastomas: New Directions In Risk Stratification
Prabal Deb
Neurology India, 2006
View PDFchevron_right
Systems Biology Approach for the Identification of Diagnostic and Therapeutic Targets in Medulloblastomas
Vinayak Pachapur
Current Pharmacogenomics and Personalized Medicine, 2013
View PDFchevron_right
Subtypes of medulloblastoma have distinct developmental origins
Frederick Boop
Nature, 2010
View PDFchevron_right
The Treatment Outcomes in Children with Medulloblastoma
Hilal Akbas
The Journal of Pediatric Academy, 2020
View PDFchevron_right
Integrated Genomics Identifies Five Medulloblastoma Subtypes with Distinct Genetic Profiles, Pathway Signatures and Clinicopathological Features
Wiesława Grajkowska
PLoS ONE, 2008
View PDFchevron_right
Molecular subgroups of medulloblastoma: the current consensus
Scott Pomeroy
Acta Neuropathologica, 2011
View PDFchevron_right
Clinical Insights: Optimal Therapy of Pediatric Medulloblastoma
Mustafa Nadi
2015
View PDFchevron_right
Molecular fingerprints of medulloblastoma and their application to clinical practice
Scott Pomeroy
Future Oncology, 2011
View PDFchevron_right
The molecular landscape and associated clinical experience in infant medulloblastoma: prognostic significance of second‐generation subtypes
Dr Louise Pease
Neuropathology and Applied Neurobiology, 2020
View PDFchevron_right
Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma
Brad Poore
Cancers, 2020
View PDFchevron_right
Neuro-Oncology Biological background of pediatric medulloblastoma and ependymoma: A review
Judith de Bont
2008
View PDFchevron_right
Clinical, Histological, and Molecular Prognostic Factors in Childhood Medulloblastoma: Where Do We Stand?
Charikleia Ntenti
Diagnostics, 2023
View PDFchevron_right
Medulloblastoma biology in the post-genomic era
Scott Pomeroy
Future Oncology, 2012
View PDFchevron_right
Novel mutations target distinct subgroups of medulloblastoma
Martine Roussel
Nature, 2012
View PDFchevron_right